Mixtard 30/Mixtard 30 Penfill諾和靈 30R

Mixtard 30/Mixtard 30 Penfill


Novo Nordisk


Firma Chun Cheong
Concise Prescribing Info
Per 100 IU/mL Human insulin (recombinant DNA origin) consists of dissolved insulin 30%, isophane insulin 70%
Dosage/Direction for Use
SC Individualized dosing. Usual insulin requirement: 0.3-1 IU/kg/day.
Should be taken on an empty stomach: Administer 30 min before meals.
Special Precautions
Risk of hyperglycaemia w/ inadequate dosage or discontinuation of treatment, especially in type 1 DM. Risk of hypoglycaemia w/ excessive insulin dose, omitted meal or unplanned, strenuous physical exercise. Change in usual warning symptoms of hypoglycaemia in patients w/ greatly improved blood glucose control eg, by intensified therapy, & w/ longstanding diabetes. Transfer to another type or brand of insulin; change in strength, brand (manufacturer), type, origin (human insulin, insulin analogue) &/or method of manufacture. Patients w/ concomitant illness, especially infections & feverish conditions; concomitant diseases in the kidney, liver or affecting the adrenal, pituitary, or thyroid gland; patients travelling between different time zones. Rotate inj site continuously to reduce or prevent inj site reactions. Do not use in insulin infusion pumps. Cases of CHF in combination w/ thiazolidinediones. May impair ability to drive & use machines. Pregnancy & lactation.
Adverse Reactions
Hypoglycaemia. Refraction anomalies, oedema, inj site reactions (pain, redness, hives, inflammation, bruising, swelling & itching at the inj site).
Drug Interactions
Reduced patient's insulin requirement w/ oral antidiabetics, MAOIs, non-selective β-blockers, ACE inhibitors, salicylates, anabolic steroids & sulphonamides. Increased patient's insulin requirement w/ OCs, thiazides, glucocorticoids, thyroid hormones, sympathomimetics, growth hormone & danazol. Masked symptoms of hypoglycaemia & delayed recovery from hypoglycaemia w/ β-blockers. Either increased or decreased insulin requirements w/ octreotide/lanreotide. Intensified or reduced hypoglycemic effects w/ alcohol.
MIMS Class
Insulin Preparations
ATC Classification
A10AD01 - insulin (human) ; Belongs to the class of intermediate-acting combined with fast-acting insulins and analogues. Used in the treatment of diabetes.
Mixtard 30 inj
10 mL x 1's
Mixtard 30 Penfill 3 mL
3 mL x 5 × 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in